- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: artemether-lumefantrine (ALN)
Total 256567 results
-
Beijing Tiantan HospitalBeijing Chao Yang Hospital; Henan Provincial People's Hospital; Beijing Neurosurgical...Not yet recruitingIntracranial Aneurysm | Aneurysm, Brain | Inflammation VascularChina
-
Diakonhjemmet HospitalThe Research Council of Norway; South-Eastern Norway Regional Health AuthorityCompletedRheumatoid ArthritisNorway
-
Alliancells Bioscience Corporation LimitedUnknownRheumatoid ArthritisChina
-
National Institute of Allergy and Infectious Diseases...Completed
-
Liga Panamericana de Asociaciones de Reumatologia...RecruitingArthritis, Rheumatoid | Arthritis, Psoriatic | SpondyloarthritisArgentina
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Rhode Island HospitalCompletedAcute AppendicitisUnited States
-
GlaxoSmithKlineCompleted
-
Proto Pharma LtdXidea Solutions LimitedCompletedFalciparum Malaria
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedChildhood GlaucomaItaly
-
TakedaCompletedType 2 Diabetes Mellitus and MicroalbuminuriaJapan
-
Lori A. Schweickert, MDShireCompleted
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, Turkey, India, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, Italy, United Kingdom, Poland, Taiwan, Colombia, France, Germany, Mexico
-
Centre Hospitalier Universitaire de Saint EtienneCompletedLacrimal Apparatus Diseases | Blepharitis | Corneal DiseaseFrance
-
Novartis PharmaceuticalsMedicines for Malaria VentureCompletedMalariaUnited Kingdom
-
Mereo BioPharmaCompletedInteractionUnited States
-
Professor Francois VenterUniversity of Cape TownCompletedTuberculosis | HIV-1-infectionSouth Africa
-
Children's Hospital of Fudan UniversityCompletedIdiopathic Precocious PubertyChina
-
Novartis PharmaceuticalsMedicines for Malaria VentureCompleted
-
Janssen Scientific Affairs, LLCCompletedHIV Infections | Pregnancy | HIVUnited States, Puerto Rico
-
Novartis PharmaceuticalsMedicines for Malaria VentureCompleted
-
Jason Hsu, MDCompletedScleral BucklingUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); Children's Cancer GroupCompletedLymphoma | Cardiac ToxicityUnited States, Australia, Canada
-
Alnylam PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsTerminated
-
Alnylam PharmaceuticalsCompletedSolid TumorsUnited States, Spain
-
Regeneron PharmaceuticalsNot yet recruitingNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD) | Genetic Risk Factor
-
Alnylam PharmaceuticalsTerminatedNonalcoholic Steatohepatitis | NASHUnited States, Bulgaria, United Kingdom, Belgium, Turkey
-
Alnylam PharmaceuticalsTerminatedIgA Nephropathy (IgAN) | Berger Disease | Glomerulonephritis, IgACanada, Malaysia, France, Sweden, United Kingdom, Philippines, Singapore, Spain, Taiwan
-
Regeneron PharmaceuticalsRecruitingNon-alcoholic Steatohepatitis (NASH) | Metabolic Dysfunction Associated Steatohepatitis (MASH)United States, Korea, Republic of, Puerto Rico, Japan
-
Alnylam PharmaceuticalsTerminatedZZ Type Alpha-1 Antitrypsin Deficiency Liver DiseaseUnited Kingdom
-
Regeneron PharmaceuticalsRecruitingHealthy Volunteers | Non-alcoholic Fatty Liver Disease (NAFLD)United States
-
Alnylam PharmaceuticalsCompletedATTR Amyloidosis | Transthyretin (TTR)-Mediated Amyloidosis | Familial Amyloidotic Polyneuropathy (FAP) | Familial Amyloid NeuropathiesFrance, Germany, Portugal, United Kingdom, Sweden, Spain
-
Regeneron PharmaceuticalsCompletedParoxysmal Nocturnal HemoglobinuriaUnited Kingdom
-
Regeneron PharmaceuticalsNot yet recruiting
-
Alnylam PharmaceuticalsRecruitingType 2 Diabetes Mellitus (T2DM)Canada, United States
-
Alnylam PharmaceuticalsCompletedAmyloidosis, Familial | Transthyretin AmyloidosisFrance, Germany, Italy, Portugal, Spain, Sweden, United Kingdom
-
Regeneron PharmaceuticalsAlnylam PharmaceuticalsCompleted
-
Mario Negri Institute for Pharmacological ResearchAlnylam PharmaceuticalsWithdrawn
-
Regeneron PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaTaiwan, Korea, Republic of, Turkey, Spain, Thailand, Singapore, Japan, Canada, Malaysia, Poland, Italy, Romania
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 (PH1) | Primary HyperoxaluriaUnited States, France, United Kingdom, Israel, Germany
-
Alnylam PharmaceuticalsActive, not recruitingHypertensionUnited States, Canada, United Kingdom, Puerto Rico, Ukraine
-
Alnylam PharmaceuticalsNot yet recruitingMild to Moderate Hypertension
-
Alnylam PharmaceuticalsApproved for marketingPrimary HyperoxaluriaBelgium
-
Alnylam PharmaceuticalsCompletedPolyneuropathy | Hereditary Transthyretin-mediated (ATTRv) AmyloidosisUnited States
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, France; Fondation de l'Avenir; Fondation de France; ALN Implants...CompletedVenous Thrombosis | Pulmonary EmbolismFrance
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGTFrance, United Kingdom, Netherlands, Israel, Germany
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Italy, France, Lebanon, Belgium, Netherlands, Israel, United Arab Emirates, Australia, Jordan, Turkey
-
Alnylam PharmaceuticalsCompletedRespiratory Syncytial Virus InfectionsUnited States, Australia
-
SanofiCompletedHemophilia A | Hemophilia BBulgaria, Switzerland, United Kingdom, United States, Russian Federation